Home > PE Ratio > INDEGENE

INDEGENE
PE (Price/Earnings) Ratio

The Current P/E Ratio of INDEGENE is 27.38.

Share Price ₹499.8Feb 03,2026
Market Cap ₹12,019.0 Cr
Earnings-TTM₹439.0 CrTTM-Consolidated Results
Price/Earnings27.38xCalculated as Market Cap/Earnings
Explore Stock Analytics
AD     Remove this Ad
INDEGENE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of INDEGENE

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of INDEGENE is calculated as :

Current Market Cap [ ₹12,019.0 Cr] as on Feb 03,2026

(/) Earnings [ ₹439.0 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 27.38x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for INDEGENE , the investors are currently willing to pay 27.38 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INDEGENE !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of INDEGENE over the last five years.

Historical PE (Price/Earnings) ratio chart of INDEGENE


PE Ratio Performance Analysis for INDEGENE

- INDEGENE 's latest p/e ratio is 27.38x.

- INDEGENE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 6.81x.

- INDEGENE 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, INDEGENE 's p/e ratio peaked in Mar2025 at 34.05x.

- INDEGENE 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does INDEGENE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
INDEGENE 439.0027.3812,019.0
SUN PHARMACEUTICAL INDUSTRIES LTD11,001.4037.14408,559.0
DIVIS LABORATORIES LTD2,485.0066.33164,827.0
CIPLA LTD4,544.7023.51106,825.0
TORRENT PHARMACEUTICALS LTD2,140.0063.99136,942.0
DR REDDYS LABORATORIES LTD5,508.7018.71103,077.0
MANKIND PHARMA LTD1,796.6549.5388,996.6
ZYDUS LIFESCIENCES LTD4,973.4018.2790,857.9
LUPIN LTD4,347.5322.9899,911.5
AUROBINDO PHARMA LTD3,447.7520.6671,215.0
ABBOTT INDIA LTD1,508.9537.8457,096.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INDEGENE 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.27x
Max industry PE 66.33x
Median industry PE 27.38x
Average industry PE 35.12x



You may also like the below Video Courses